연구성과로 돌아가기

2022 연구자 정보 (143 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Pacurar, Daniela
(Pacurar, D) ⓘ 		Univ Med & Pharm Bucharest, Grigore Alexandrescu Emergency Clin Hosp Children, Bucharest, Romania
Carol Davila Univ Med & Pharm Bucharest, Dept Pediat, Grigore Alexandrescu Emergency Childrens Hosp Buc, Bucharest, Romania ⓘ 		IYS-1131-2023
Pacurar, Daniela ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY ⓘ frida.abramov@gilead.com; ⓘ
Park, Joon Woo
(Park, JW) ⓘ 		Kyungpook Natl Univ, Sch Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] NONINVASIVE PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C: A MULTICENTER STUDY ⓘ SCIE ⓘ 5.9 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Park, Jun-Young
(Park, JY) ⓘ 		Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon 21999, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] Greater Plasma Protein Adsorption on Mesoporous Silica Nanoparticles Aggravates Atopic Dermatitis ⓘ SCIE ⓘ 5.9 NANOSCIENCE & NANOTECHNOLOGY;PHARMACOLOGY & PHARMACY ⓘ dkhang@gachon.ac.kr;shkim72@knu.ac.kr; ⓘ
Park, Jung Gil
(Park, JG) ⓘ 		Yeungnam Univ, Coll Med, Internal Med, Gyongsan, South Korea
Yeungnam Univ, Dept Internal Med, Coll Med, 170 Hyonchung Ro, Daegu 42415, South Korea
Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea
Yeungnam Univ, Coll Med, Internal Med, Daegu, South Korea
Yeungnam Univ, Coll Med, Dept Internal Med, Daegu 42415, South Korea
Yeungnam Univ, Coll Med, Gyongsan, South Korea ⓘ 		AAK-5167-2020
Park, Jung ⓘ
ⓘ 		[JCR상위 5.9] IMPACT OF SARCOPENIA AND ADVANCED FIBROSIS ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE
[JCR상위 38.3] Circular Noncoding RNA hsacᵢᵣc₀₀₀₃₅₇₀ as a Prognostic Biomarker for Hepatocellular Carcinoma
[JCR상위 34.9] Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial
[JCR상위 3.8] Myosteatosis and excessive visceral adipose tissue as prognostic factors in patients with hepatocellular carcinoma treated with sorafenib
[JCR상위 37.6] Deep Learning-Based Four-Region Lung Segmentation in Chest Radiography for COVID-19 Diagnosis
[JCR상위 5.9] NONINVASIVE PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C: A MULTICENTER STUDY
[JCR상위 3.8] Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY
GENETICS & HEREDITY
MULTIDISCIPLINARY SCIENCES
MEDICINE, GENERAL & INTERNAL ⓘ 		psyoung0419@gmail.com;keunhur@knu.ac.kr;
jheo@pusan.ac.kr;wytak@knu.ac.kr;
kmggood111@naver.com;
younggon2.kim@gmail.com;KKIM24@partners.org;dwu6@mgh.harvard.edu;HREN2@mgh.harvard.edu;MKALRA@mgh.harvard.edu;psyoung0419@gmail.com;deblue00@naver.com;gsnrs@naver.com;kbs9225@cu.ac.kr;chung50@dsmc.or.kr;li.quanzheng@mgh.harvard.edu;
psyoung0419@gmail.com; ⓘ
Raju, Sri Srinivasa
(Raju, S) ⓘ 		제1저자 Natl Inst Technol Silchar, Dept Math, Silchar, India ⓘ GNH-4935-2022
M, Sri Srinivasa Raju ⓘ
ⓘ 		[JCR상위 5.9] A twin-archive guided decomposition based multi/many-objective evolutionary algorithm ⓘ SCIE ⓘ 5.9 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, THEORY & METHODS ⓘ mallipeddi.ram@gmail.com; ⓘ
Reig, Maria
(Reig, M) ⓘ 		Barcelona Univ, Hosp Clin Barcelona, Barcelona Clin Liver Canc BCLC, Barcelona, Spain ⓘ ABB-5414-2021
Reig, Maria ⓘ
ⓘ 		[JCR상위 5.9] OUTCOMES BY BASELINE LIVER FUNCTION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TREMELIMUMAB AND DURVALUMAB IN THE PHASE 3 HIMALAYA STUDY ⓘ SCIE ⓘ 5.9 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Rosenthal, Philip
(Rosenthal, P) ⓘ 		Univ Calif San Francisco, San Francisco, CA USA
Univ Calif San Francisco, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA ⓘ 		AGG-3493-2022
Rosenthal, Philip ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY ⓘ frida.abramov@gilead.com; ⓘ
Schwarz, Kathleen B.
(Schwarz, KB) ⓘ 		제1저자 Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol, Cincinnati, OH USA ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) ⓘ SCIE ⓘ 5.9 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Shalimar
(Shalimar) ⓘ 		All India Inst Med Sci, Dept Gastroenterol, New Delhi, India ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY ⓘ frida.abramov@gilead.com; ⓘ
Shim, Hyo Sup
(Shim, HS) ⓘ 		교신저자 Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea ⓘ ABI-6190-2020
Shim, Hyo ⓘ 		0000-0002-5718-3624
Shim, Hyo Sup ⓘ 		[JCR상위 5.9] Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement ⓘ SCIE ⓘ 5.9 PATHOLOGY ⓘ shimhs@yuhs.ac; ⓘ
Shin, Min Jun
(Shin, MJ) ⓘ 		Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon 21999, South Korea
Gachon Univ, Dept Hlth Sci & Technol, GAIHST, Incheon 21999, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] Greater Plasma Protein Adsorption on Mesoporous Silica Nanoparticles Aggravates Atopic Dermatitis ⓘ SCIE ⓘ 5.9 NANOSCIENCE & NANOTECHNOLOGY;PHARMACOLOGY & PHARMACY ⓘ dkhang@gachon.ac.kr;shkim72@knu.ac.kr; ⓘ
Sokal, Etienne
(Sokal, É) ⓘ 		Catholic Univ Louvain, Cliniques St Luc, Ottignies, Belgium
Catholic Univ Louvain, Pediat Hepatol & Gastroenterol & Cell Transplant, Clin Univ St Luc, Brussels, Belgium ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY ⓘ frida.abramov@gilead.com; ⓘ
Song, Jeongeun
(Song, J) ⓘ 		Daegu Catholic Univ, Sch Med, Gyongsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] NONINVASIVE PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C: A MULTICENTER STUDY ⓘ SCIE ⓘ 5.9 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Tanasanvimon, Suebpong
(Tanasanvimon, S) ⓘ 		Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Bangkok, Thailand ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] OUTCOMES BY BASELINE LIVER FUNCTION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TREMELIMUMAB AND DURVALUMAB IN THE PHASE 3 HIMALAYA STUDY ⓘ SCIE ⓘ 5.9 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Tandon, Manish
(Tandon, M) ⓘ 		MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India
M V Hosp & Res Ctr, Lucknow, Uttar Pradesh, India ⓘ
ⓘ
ⓘ 		[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B ⓘ 		SCIE ⓘ 3.8 GASTROENTEROLOGY & HEPATOLOGY ⓘ frida.abramov@gilead.com; ⓘ
페이지 이동: